Rapamycin (Sirolimus) Clinical Evidence Guide: 2026 Medical Standards
Last updated: June 7, 2026 Rapamycin (Sirolimus) is a macrolide compound originally discovered on Easter Island. Under 2026 medical standards, it is the most robust, pharmacologically validated geroprotector (anti-aging drug) in clinical existence. By acting as a direct inhibitor of the mTOR pathway, it forces the cellular machinery to shift from growth and replication into … Read more